A detailed history of Macquarie Group LTD transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 995,287 shares of AXSM stock, worth $98.2 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
995,287
Previous 1,073,242 7.26%
Holding current value
$98.2 Million
Previous $86.4 Million 3.51%
% of portfolio
0.1%
Previous 0.1%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$78.93 - $95.84 $6.15 Million - $7.47 Million
-77,955 Reduced 7.26%
995,287 $89.4 Million
Q2 2024

Aug 09, 2024

BUY
$65.72 - $80.5 $24.5 Million - $30 Million
372,832 Added 53.23%
1,073,242 $86.4 Million
Q1 2024

May 14, 2024

BUY
$69.39 - $97.64 $46.7 Million - $65.7 Million
672,886 Added 2444.72%
700,410 $55.9 Million
Q4 2023

Feb 14, 2024

BUY
$57.42 - $83.61 $345,036 - $502,412
6,009 Added 27.93%
27,524 $2.19 Million
Q3 2023

Nov 14, 2023

SELL
$69.25 - $82.21 $1.7 Million - $2.02 Million
-24,576 Reduced 53.32%
21,515 $1.5 Million
Q2 2023

Aug 14, 2023

BUY
$58.41 - $90.35 $1.53 Million - $2.37 Million
26,187 Added 131.57%
46,091 $3.31 Million
Q1 2023

May 15, 2023

BUY
$58.39 - $75.0 $87,468 - $112,350
1,498 Added 8.14%
19,904 $1.23 Million
Q4 2022

Feb 21, 2023

SELL
$39.94 - $79.72 $371,481 - $741,475
-9,301 Reduced 33.57%
18,406 $1.42 Million
Q3 2022

Nov 14, 2022

SELL
$36.06 - $69.85 $235,111 - $455,421
-6,520 Reduced 19.05%
27,707 $1.24 Million
Q2 2022

Aug 15, 2022

SELL
$21.74 - $46.75 $109,721 - $235,947
-5,047 Reduced 12.85%
34,227 $1.31 Million
Q1 2022

May 16, 2022

BUY
$23.7 - $41.39 $307,507 - $537,035
12,975 Added 49.34%
39,274 $1.63 Million
Q4 2021

Feb 11, 2022

BUY
$30.7 - $43.36 $1,657 - $2,341
54 Added 0.21%
26,299 $994,000
Q3 2021

Nov 12, 2021

BUY
$19.91 - $68.26 $32,015 - $109,762
1,608 Added 6.53%
26,245 $865,000
Q2 2021

Aug 13, 2021

BUY
$50.63 - $73.5 $149,155 - $216,531
2,946 Added 13.58%
24,637 $1.66 Million
Q1 2021

May 14, 2021

BUY
$55.91 - $81.44 $153,808 - $224,041
2,751 Added 14.52%
21,691 $1.23 Million
Q4 2020

Feb 16, 2021

BUY
$66.31 - $86.52 $1.18 Million - $1.54 Million
17,772 Added 1521.58%
18,940 $1.54 Million
Q2 2020

Aug 11, 2020

BUY
$49.87 - $98.69 $58,248 - $115,269
1,168 New
1,168 $96,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.23B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.